The QualityStocks Daily Stock List
- Planet 13 Holdings, Inc. (PLNHF)
- Relmada Therapeutics, Inc. (RLMD)
- Rubicon Organics, Inc. (ROMJF)
- Chesapeake Gold Corp. (CHPGF)
- Emerald Bioscience, Inc. (EMBI)
- Humanigen, Inc. (HGEN)
- Medicure, Inc. (MCUJF)
- Zinc One Resources, Inc. (ZZZOF)
- Blue Eagle Lithium, Inc. (BEAG)
- American Rebel Holdings, Inc. (AREB)
- Northsight Capital, Inc. (NCAP)
- Petro River Oil Corp. (PTRC)
- Creative Medical Technology Holdings, Inc. (CELZ)
- Dakota Territory Resource Corp. (DTRC)
Planet 13 Holdings, Inc. (PLNHF)
Profit Confidential, Pot Stock News, TipRanks, Small Cap Power, Micro Small Cap, NIC Investors, TradingView, InvestorsHub, InvestorX, Market Screener, GlobeNewswire, Midas Letter, PR Newswire, Investing.com, Simply Wall St, Wallet Investor, Proactive Investors, Stockwatch, New Cannabis Ventures, and Stockhouse reported previously on Planet 13 Holdings, Inc. (PLNHF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Planet 13 Holdings, Inc. is a foremost vertically-integrated Nevada cannabis company listed on the OTCQX. The Company cultivates, produces, and distributes medical and recreational cannabis in Nevada. It has award-winning cultivation, production, as well as dispensary operations in Las Vegas, Nevada. The Company has its Medizin, TRENDI, and Leaf & Vine brands. Planet 13 Holdings has its corporate headquarters in Las Vegas.
The Company’s mission is to build a recognizable worldwide brand known for world-class dispensary operations and a creator of unique cannabis products. It is a vertically integrated leader in the delivery of retail concepts and cultivations in the fast growing Nevada cannabis market. Planet 13 features best-in-class technology solutions to innovative retail design.
Planet 13 owns the world’s largest cannabis store near the Las Vegas Strip. The Planet 13 Cannabis Entertainment Complex offers a premier customer experience centered on inventive interactive entertainment and first-rate cannabis products. Planet 13 is quickly expanding into its 112,000 square foot site for Phase II.
The Planet 13 Superstore acts as a showcase for an increasing portfolio of branded products. These include vapes, edibles, pre-rolls, as well as concentrates. The Company’s aim is to operate ultra-high-end dispensaries in tier-one markets across the nation and to sell their brands; Medizin, TRENDI, and Leaf & Vine, in their branded stores and wholesale.
Medizin provides an assortment of award-winning products. All Medizin plant genetics are hand-selected, starting with proprietary award-winning strand Chloe. TRENDI specializes in expertly crafted cannabis products. Employing leading-edge technology and also a unique visual approach, TRENDI is able to deliver a first-rate disposable vape pen product. Leaf & Vine focuses on cannabis concentrates and enjoyable flavors. Leaf & Vine disposable vapes are created with handpicked strains and high-quality vaporizing technology.
Planet 13 also has its Coffee For The Planet cafe. It is in the Planet 13 Superstore and offers an innovative relaxing greenhouse environment. Coffee For The Planet’s primary goal is to create an intimate atmosphere and quality coffee.
The Company also has its Planet M brand. Planet M features high-end products. These are custom formulated and curated with full-spectrum and CBD (cannabidiol) isolate.
Recently, Planet 13 announced that it added HaHa Gummies™ and Dreamland Chocolates™ to its growing in-house brand portfolio. HaHa Gummies and Dreamland Chocolates along with Medizin, TRENDI and Leaf & Vine will be produced in the Company’s new 15,000 sq. ft. customer-facing production facility at the Planet 13 Las Vegas Cannabis Entertainment Complex (the SuperStore).
Yesterday, Planet 13 announced that it served an average of 1,937 customers per day in July at an average ticket of $90.41 from the Planet 13 Las Vegas Cannabis Entertainment Complex. The expectation is that Planet 13’s Phase II expansion, which includes coffee shop, bistro, customer-facing production facility, and event space, will produce increased visitor traffic as new attractions and spending opportunities are added to the SuperStore.
Planet 13 Holdings, Inc. (PLNHF), closed Friday's trading session at $1.984, up 1.2245%, on 196,959 volume with 268 trades. The average volume for the last 3 months is 275,387 and the stock's 52-week low/high is $0.50150001/$2.70000004.
Relmada Therapeutics, Inc. (RLMD)
NetworkNewsWire, OTC Markets, Wallet Investor, Capital Cube, Real Investment Advice, Zacks, Super Stock Screener, Simply Wall St, Market Screener, Equities, Trading View, Marketbeat, Street Insider, Stockhouse, Streetwise Reports, MarketWatch, and InvestorsHub reported previously on Relmada Therapeutics, Inc. (RLMD), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Relmada Therapeutics, Inc. is developing REL-1017 (dextromethadone) in manifold indications. RELM-1017 is in Phase 2 for treatment resistant depression and preclinical testing for additional indications. In essence, Relmada Therapeutics develops novel therapies for the treatment of central nervous system (CNS) diseases. A clinical-stage company, Relmada Therapeutics lists on the OTC Markets Group’s OTCQB. The Company is headquartered in New York, New York.
The expectation is that Relmada Thereapeutics’ approach will reduce clinical development risks and costs. This is while potentially delivering valuable products to address areas of high unmet medical needs.
The Company’s lead program is the above-mentioned dextromethadone (REL-1017). This is an N-methyl-D-aspartate (NMDA) receptor antagonist. NMDA receptor antagonists may have potential in the treatment of a range of psychiatric and neurological disorders associated with an array of cognitive, neurological, as well as behavioral symptoms.
Relmada is targeting major advances in the treatment of CNS disorders. At present, REL-1017 is in a Phase 2a trial for the treatment of Major Depressive Disorder (MDD). Furthermore, there is considerable potential in numerous additional indications. This includes Rett Syndrome.
Relmada Therapeutics also has additional valuable pipeline assets for partnering. These include REL-1015 Levocap ER – a Phase 3-ready abuse deterrent formulation of a highly-potent opioid. Assets also include REL-1028 BuTab - an oral formulation of modified release buprenorphine for chronic pain. Additionally, assets include REL-1021 MepiGel – a novel topical version of local anesthetic mepivacaine for the treatment of painful peripheral neuropathies.
Recently, Relmada Therapeutics announced that the last subject completed dosing with REL-1017 (dextromethadone) in the Company's double-blind, placebo-controlled Phase 2 clinical study evaluating the safety and efficacy of REL-1017 as an adjunctive treatment in patients affected by treatment-resistant depression. Relmada expects to announce topline results from the study in Q3 of 2019.
The Phase 2 study of REL-1017 in treatment resistant depression is a Phase 2, multicenter, randomized, double-blind, placebo-controlled 3-arm study. This study is to assess the safety and tolerability of multiple oral doses of REL-1017 25 mg and 50 mg as adjunctive therapy in the treatment of patients diagnosed with Major Depressive Disorder (MDD). Subjects in the study are adults with MDD who have experienced an inadequate response to one to three courses of treatment with an antidepressant medication. The study enrolled 62 subjects at approximately 10 sites in the U.S.
Relmada Therapeutics, Inc. (RLMD), closed Friday's trading session at $2.24, up 1.8182%, on 26,453 volume with 31 trades. The average volume for the last 3 months is 33,789 and the stock's 52-week low/high is $0.800000011/$3.41799998.
Rubicon Organics, Inc. (ROMJF)
TheCannalysts, Pot Stock News, Investors News, Financial Buzz, BioSpace, Green Market Report, OTC Markets, Technical420, CannabisMarketCap, Trading View, Stockhouse, Stockwatch, and Investorx reported earlier on Rubicon Organics, Inc. (ROMJF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Rubicon Organics, Inc. is a Licensed Producer (LP) focused on building super-premium organic cannabis brands (Organic certification pending from FVOPA) with operations in Canada, Washington and California. Its flagship Canadian facility is a 125,000 sq. ft. state-of-the-art hybrid greenhouse with industry-leading LED lighting. This facility is on a 20-acre property in Delta, British Columbia. Rubicon Organics has its headquarters in Vancouver, British Columbia. The Company lists on the OTC Markets’ OTCQX.
Rubicon Organics has one of the largest licensed footprints for organic cannabis in Canada. Its team wrote the first organic regulatory standard for certified organic cannabis production. The Company has custom designed facilities in the best growing climates, a European distribution partnership secured, and multi-jurisdictional operations and sales. In addition, it has distinguished brands in influential markets.
Rubicon’s plants are grown in proprietary soil made with certified organic ingredients. Each stage of the growing process is carried out by hand - from planting to packaging. Everything that goes into its plants comes from the ground and the ocean. Its process replicates outdoor growing techniques.
The Company’s Washington facility is a newly constructed 40,000 square-foot high-tech hybrid greenhouse. Rubicon has started production in both facilities with a combined Phase I capacity of 15,500 kg annually. This includes 4,500 kg leased to a Washington State licensed operator applying Rubicon Organics' proprietary organic cultivation methods. Furthermore, Rubicon owns two award-winning U.S. cannabis brands. One is 1964 Supply Co.™ in California. The other is Doctor & Crook Co.™ in Washington.
In July, Rubicon Organics announced that it received organic certification from the Fraser Valley Organics Producers Association (FVOPA) at its flagship 125,000-square-foot hybrid greenhouse facility in Delta, British Columbia. Accordingly, Rubicon is now positioned to supply certified organic, super-premium cannabis grown at scale to a market where organic products are in high demand, short supply and priced at significant premiums.
Additionally, in July, Rubicon Organics announced that it is the first cannabis company in Canada to receive Environmental Farm Plan certification from the British Columbia Ministry of Agriculture. Therefore, Rubicon is being recognized as an industry leader for its commitment to sustainability and environmental best practices.
Jesse McConnell, Chief Executive Officer and Co-Founder of Rubicon Organics, said, “Every step we take is guided by a companywide commitment to cultivating incredible cannabis while also doing what is best for the planet – a commitment that we believe will appeal to both consumers and investors alike. Through the EFP certification process, we have established strong relationships with provincial regulators and are excited to work alongside them to not only adhere to industry best practices but to also help set those standards.”
Rubicon Organics, Inc. (ROMJF), closed Friday's trading session at $2.0066, off by 0.392157%, on 350 volume with 1 trade. The average volume for the last 3 months is 2,185 and the stock's 52-week low/high is $1.29814994/$2.60999989.
Chesapeake Gold Corp. (CHPGF)
Investor Intel, Silicon Investor, ResearchPool, Junior Mining Network, Investors Hangout, Wallet Investor, StockInvest.us, Dividend Investor, Geology for Investors, 24hGold, Stockhouse, Gold Stock Data, TradingView, Northern Miner, Canadian Mining Report, and InvestorsHub reported earlier on Chesapeake Gold Corp. (CHPGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQX-listed, Chesapeake Gold Corp. concentrates on the exploration and development of precious metals projects in North America. The Company owns the Metates project. Metates is in Durango State, Mexico. Metates is one of the largest undeveloped gold – silver - zinc deposits globally. Chesapeake Gold has its corporate office in Vancouver, British Columbia. Since 1994, Chesapeake's management team has been operating together as an exploration organization in Mexico and Central America. The Company also has an office in Durango, Mexico.
Metates benefits from its highest ore grade early in the mine life, a low strip ratio, and also close proximity to vital existing infrastructure. Metates has the option to be an initial 30,000 tpd or 60,000 tpd mine that expands to full nameplate capacity. A pre-feasibility study by M3 Engineering indicates at the throughput rate of 120,000 tpd, the yearly production would be 659,000 ounces of gold, 16 million ounces of silver, and 143 million pounds of zinc over 25 years. Life of mine All-In Sustaining Costs (AISC) including by-product credits, are $472 per ounce.
Chesapeake Gold also has its Yarely, La Gitana, La Cecilia, and Tatatila projects in Mexico. In the United States, the Company has its Talapoosa Project in Nevada. In Guatemala, Chesapeake has its El Escorpion Project.
Today, Chesapeake Gold announced that it exercised an option to re-purchase a one percent Net Smelter Returns royalty (NSR) on its 100 percent owned Metates gold-silver-zinc project situated in Durango State, Mexico. The NSR was purchased for US$9.0 million from Wheaton Precious Metals (Cayman) Co., a subsidiary of Wheaton Precious Metals Corp.
Chesapeake Gold assigned its interest in a 1.5 percent NSR (Royalty) on Metates to Wheaton in August of 2014 in consideration of US$9.0 million. As part of the assignment, Chesapeake had the right at any time for a period of five years to purchase two-thirds of the Royalty (the 1 percent NSR from Wheaton) for US$9.0 million, with Wheaton continuing to hold a 0.5 percent NSR.
Chesapeake Gold Corp. (CHPGF), closed Friday's trading session at $2.9231, up 16.7046%, on 79,706 volume with 124 trades. The average volume for the last 3 months is 18,153 and the stock's 52-week low/high is $1.02999997/$2.92919993.
Emerald Bioscience, Inc. (EMBI)
Stock Market Watch, Zacks, Potstocks.online, Real Investment Advice, Micro Small Cap, Market Wire News, CannabisMarketCap, Market Screener, TMX Money, MacroTrends, Proactive Investors, Stockopedia, TradingView, Stockhouse, InvestorsHub, Stockwatch, GlobeNewswire, and Simply Wall St reported previously on Emerald Bioscience, Inc. (EMBI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Emerald Bioscience, Inc. is a biopharmaceutical company listed on the OTC Markets’ OTCQB. It concentrates on advancing the medical benefits of cannabinoid-based therapies via its novel, proprietary, multi-cannabinoid drug platform for the treatment of significant unmet medical needs. Emerald has proprietary technology licensed from the University of Mississippi. The Company’s strategy is to clinically develop several proprietary biosynthetic compounds, alone or in combination with corporate partners. Emerald Bioscience has its corporate headquarters in Long Beach, California.
Emerald Bioscience is part of the Emerald Group. The Emerald Group consists of numerous companies centered on developing pharmaceutical, botanical, and nutraceutical products providing wellness and medical benefits by interacting with the human body’s endocannabinoid system.
Emerald Bioscience is developing novel ways to deliver cannabinoid-based drugs for specific indications. The objective is optimizing the clinical effects of such drugs while limiting potential adverse events.
Fundamentally, Emerald Bioscience concentrates on the discovery, development, and commercialization of new chemical entities from a class of chemically diverse compounds named cannabinoids. These molecules display pleiotropic activity by virtue of selectively binding to two kinds of cannabinoid receptors (CB1 and CB2) located throughout manifold organ systems in the body.
At present, the Company is developing a novel and proprietary class of product candidates designed to improve therapeutic options based on chemical engineering, which allow drug candidates to have enhanced bioavailability and more predictable pharmacokinetics. This leads to optimized efficacy and safety.
To date, preclinical studies of Emerald’s lead product candidate, NB1111 (THCVHS), have demonstrated the potential to decrease intraocular pressure and the reduction of biomarkers associated with inflammatory and fibrotic reactions to injury. In addition, the neuroprotective qualities of the proprietary cannabinoids are undergoing study to measure the direct neuroprotective capability of the molecules to preserve vision, especially in glaucoma.
Recently, Emerald Bioscience announced that newly published scientific data highlight the superior penetration of the Company’s drug candidate, NB2222, into ocular tissues versus natural cannabidiol (CBD). Additionally, NB2222 exhibited an ability to reach the optic nerve, opening its potential to provide ocular neuroprotection, an important goal in treating diseases that lead to vision loss.
The data were published in the peer-reviewed Journal of Ocular Pharmacology and Therapeutics in a paper titled, “Analog Derivatization of Cannabidiol for Improved Ocular Permeation.” The research was conducted by Emerald’s discovery and research colleagues at the University of Mississippi, led by Soumyajit Majumdar, PhD, Professor of Pharmaceutics and Drug Delivery and Associate Dean for Research and Graduate Programs in the School of Pharmacy.
Emerald Bioscience, Inc. (EMBI), closed Friday's trading session at $0.27, off by 5.8906%, on 62,558 volume with 34 trades. The average volume for the last 3 months is 155,626 and the stock's 52-week low/high is $0.05/$1.16999995.
Humanigen, Inc. (HGEN)
Zacks, Stocks Equity, EarningsCast, Market Screener, AI Stock Finder, Infront Analytics, Investing.com, Stockhouse, TradingView, GlobeNewswire, TMX Money, InvestorsHub, Simply Wall St reported earlier on Humanigen, Inc. (HGEN), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Humanigen, Inc. is developing its Humaneered® proprietary monoclonal antibodies to address critical unmet needs in today's most advanced cancer therapies. A biopharmaceutical enterprise, the Company is developing its portfolio of Humaneered® monoclonal antibodies centered on CAR-T optimization and immuno-oncology. Humaneering is a patented proprietary technology for converting suboptimal antibodies into human antibodies suitable for chronic therapies, in part, because of low immunogenicity. OTCQB-listed, Humanigen is based in Burlingame, California.
Derived from the Company’s Humaneered® platform, lenzilumab and ifabotuzumab, and HGEN005 are monoclonal antibodies with first-in-class mechanisms. Lenzilumab targets GM-CSF. It is in development as a potential biologic therapy to make CAR-T therapy safer and more effective, and also a potential treatment for hematologic cancers.
Ifabotuzumab targets the Eph type-A receptor 3 (EphA3). It is being explored as a potential treatment for glioblastoma multiforme (GBM) and a range of solid tumors, as an optimized naked antibody and as part of an antibody-drug conjugate, as well as a backbone for a novel CAR-T construct, and a bispecific antibody platform.
HGEN005 selectively targets the eosinophil receptor EMR1. It is being explored as a potential treatment for a range of eosinophilic diseases. This includes eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct.
In July, Humanigen announced that it entered into an exclusive global license with the Mayo Clinic to certain technologies used to create CAR-T cells lacking GM-CSF expression via various gene-editing tools. This includes CRISPR-Cas9 (GM-CSF knock-out). This license covers different patent applications and knowledge developed by Mayo in collaboration with Humanigen. These licensed technologies complement and broaden Humanigen’s leadership position in the GM-CSF neutralization space and expand the Company’s discovery platform targeted at improving CAR-T to include gene-edited CAR-T cells.
In addition, in July, Humanigen announced that it secured an exclusive global license agreement from the University of Zurich (UZH) for technology used to prevent GvHD via GM-CSF neutralization. The Humanigen license covers different patent applications filed by UZH that complement and broaden Humanigen’s leadership position in the application of GM-CSF and expand Humanigen’s development platform to include improving allogeneic HSCT. Allogeneic HSCT is a potentially curative therapy for patients with hematological cancers.
Dr. Cameron Durrant, Humanigen Chief Executive Officer, said, “Humanigen has pioneered the strategy of neutralizing GM-CSF to improve the safety and efficacy of T cell therapies. This license agreement builds on our leadership position aimed at breaking the efficacy/toxicity barrier that currently exists for T cell therapies, including allogeneic HSCT. The agreement broadens our already extensive GM-CSF neutralization intellectual property portfolio to include prevention of GvHD in allogeneic HSCT.”
Humanigen, Inc. (HGEN), closed Friday's trading session at $1.00, up 11.1111%, on 100 volume with 1 trade. The average volume for the last 3 months is 3,842 and the stock's 52-week low/high is $0.439999997/$1.54400002.
Medicure, Inc. (MCUJF)
Zacks, Private Capital Journal, StockScores, Stockhouse, StockEarnings, Barchart, Stockwatch, Streetwise Reports, Morningstar, and MarketBeat reported beforehand on Medicure, Inc. (MCUJF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Medicure, Inc. focuses on the development and commercialization of therapies for the U.S. cardiovascular market. A pharmaceutical company, its current emphasis is the marketing and distribution of AGGRASTAT® (tirofiban hydrochloride) injection, ZYPITAMAGTM (pitavastatin) tablets, and the ReDS™ device in the U.S., where they sell through its U.S. subsidiary, Medicure Pharma, Inc. Established in 1997, Medicure is based in Winnipeg, Manitoba.
The Company is a U.S focused Specialty Pharma enterprise with established sales of Aggrastat. Medicure carefully monitors opportunities within its own pipeline of products and possible acquisitions of related pharmaceutical companies in order to realize long term value. Its subsidiaries include Medicure International, Inc. (Barbados), which owns the U.S. rights to AGGRASTAT, as well as two U.S. corporations, Medicure USA, Inc. and Medicure Pharma, Inc., which distribute its products in the U.S.
Recently, Medicure announced that Dr. Neil Owens was appointed President and Chief Operating Officer of the Company effective July 1, 2019. In this capacity, Dr. Owens will be responsible for implementing Medicure’s strategic plans and overseeing daily operations. This includes the advancement and management of new and existing pharmaceutical products. Dr. Owens has worked at Medicure since 2014, in varied positions of increasing responsibility, most recently as Director, Scientific Affairs. Since May of 2016, Dr. Albert Friesen has served as Medicure’s President. He will continue to serve as Chief Executive Officer of Medicure and as Chair of its Board of Directors.
Yesterday, Medicure reported its results from operations for the quarter ended June 30, 2019. The Company recorded Net Revenue from the sale of AGGRASTAT® (tirofiban hydrochloride) of $6.2 million during the quarter ended June 30, 2019. This is in comparison to $7.2 million for the quarter ended June 30, 2018, and $4.8 million for the quarter ended March 31, 2019.
Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) for the quarter ended June 30, 2019 was $103,000. This is in comparison to adjusted EBITDA of $882,000 for the quarter ended June 30, 2018. Net Loss for the quarter ended June 30, 2019 was $957,000 (of which, $813,000 was because of a loss from foreign exchange). This is in comparison to Net Income of $1.6 million for the quarter ended June 30, 2018.
Medicure, Inc. (MCUJF), closed Friday's trading session at $3.45, even for the day, on 1,700 volume. The average volume for the last 3 months is 1,167 and the stock's 52-week low/high is $3.27999997/$5.67670011.
Zinc One Resources, Inc. (ZZZOF)
NetworkNewsWire, 4-Traders, MarketWatch, YCharts, InvestorX, InvestorsHub, Market Screener, Wall Street Profiler, Streetwise Reports, InvestorIntel, Stock of the Week, Epic Stock Picks, All Penny Stocks, Stockhouse, Dividend Investor, Insider Financial, Marketwired, Investing News, Barchart, StockInvest, Wallet Investor, Investor Ideas, and Investors Hangout reported previously on Zinc One Resources, Inc. (ZZZOF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Zinc One Resources, Inc. concentrates on the acquisition, exploration and development of prospective and advanced zinc projects in mining-friendly jurisdictions. Its key assets are the past producing Bongará Zinc Mine Project and the Charlotte-Bongará Zinc Project in Peru. The Company formerly went by the name Rockridge Capital Corp. It changed its corporate name to Zinc One Resources, Inc. in January 2017. Zinc One Resources is based in Vancouver, British Columbia.
The Company acquired Forrester Metals, Inc. in June of 2017. As a result, it acquired the Bongará Mine and Charlotte-Bongará Projects. Both host high-grade, nonsulphide zinc mineralization at or near the surface. At the Bongará Zinc Mine the mineralization is concentrated along and proximal to a NW – trending anticlinal axis over approximately 2.5 kilometers.
The Bongará Zinc Mine was mined in 2007 and 2008 by a previous owner by open-pit methods, dried at the site, and then shipped 540 kilometers westward to the coast where it was processed via a Waelz kiln. This is a processing technology usually applied to flue dust from steel mills to recover zinc. In August 2008, the mine was closed down mainly due to a drop in the price of zinc at that time.
The exploration upside at Charlotte-Bongará includes greater than 8,000 meters of drilling. This includes results of 29.5% Zn across 15.5 meters, 26.1% Zn across 12.5 meters, and 29.7% Zn across 11.5 meters.
Last month, Zinc One Resources announced the first National Instrument 43-101 (NI 43-101) Mineral Resource estimate for its Bongará Zinc Mine project in north-central Peru. Watts Griffis and McOuat Limited (WGM) prepared the estimate for the Company. A supporting NI 43-101 technical report will be available under Zinc One Resources’ profile on SEDAR at www.sedar.com and on the Company's website at www.zincone.com within 45 days of this release (dated February 5, 2019).
Yesterday, Zinc One Resources announced the results of voting at the Company’s Annual General Meeting (AGM) of shareholders that took place on March 13, 2019, in Vancouver, British Columbia. Shareholders at the AGM approved all matters. This included the appointment of the four incumbent directors - Dr. William C. Williams, Mr. Barry Girling, Mr. Greg Crowe, and Mr. Gunther Roehlig, for the following year, the re-appointment of Charlton & Co. LLP as auditors of Zinc One Resources, and the renewal of the Company's 10 percent rolling stock option plan.
Zinc One Resources, Inc. (ZZZOF), closed Friday's trading session at $0.012, up 20.00%, on 20,600 volume with 4 trades. The average volume for the last 3 months is 10,679 and the stock's 52-week low/high is $0.009449999/$0.149000003.
Blue Eagle Lithium, Inc. (BEAG)
All Penny Stocks, Simply Wall St, Nasdaq, Financial Buzz, Stockhouse, OTC Markets, Last10k, and Market Screener reported earlier on Blue Eagle Lithium, Inc. (BEAG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A lithium exploration company, Blue Eagle Lithium, Inc. engages in identifying, evaluating, and developing early-stage lithium exploration opportunities in North America. The design of the Company’s growth strategy is to maximize shareholder value through a singular emphasis on lithium exploration and development in secure and stable North American regions. OTCQB-listed, Blue Eagle Lithium has its corporate headquarters in Henderson, Nevada.
The Company’s initial property is in Railroad Valley, Nevada, a highly prospective green-fields Petro-Lithium brine target region that features numerous similarities to the nearby Clayton Valley and which Blue Eagle Lithium believes warrants an extensive exploration program. It has a 100 percent Working Interest (WI) in 276 placer claims in Railroad Valley.
The Company’s Railroad Property warrants surface and shallow drilling evaluation for possible surface-mineable lithium-rich units based on different sources of geological data. The main exploration target within the Railroad Property would be more recent playa sediments, mostly within 2,000 feet (610 meters) of the valley’s surface. Railroad Valley is an isolated sedimentary basin. It exhibits all the important attributes of a large commercial petro-lithium discovery.
Yesterday, Blue Eagle Lithium announced that it has engaged Rangefront Geological to begin an extended soil sampling program covering its original 4,000 acre land position in Railroad Valley and its recently acquired acreage, the latter of which has received only limited evaluations to date. Rangefront Geological is a premier geological contracting and consulting company based locally out of Elko, Nevada. A crew from Rangefront will be mobilized to start work on the properties with the goal to gather up to 250 near surface clay and brine samples.
In addition, Blue Eagle Lithium announced it further extended its land package through the exercise of an option agreement clause. This extends its land holdings by an additional 520 acres (26 Mineral Claims). In total, the land package now held by Blue Eagle Lithium is 5,520 acres (276 claims, approximately 2,223 Hectares).
Blue Eagle Lithium, Inc. (BEAG), closed Friday's trading session at $0.39, up 5.4054%, on 12,202 volume with 22 trades. The average volume for the last 3 months is 335,912 and the stock's 52-week low/high is $0.449999988/$3.50.
American Rebel Holdings, Inc. (AREB)
Wallet Investor, Market Screener, OTC Markets, Stockwatch, Trading View, Dividend Investor, Penny Stock Hub, Capital Cube, Investors Hangout, Stocks News Feed, Street Insider, Simply Wall St, Morningstar, 4-Traders, Barchart, Wallmine, and MarketWatch reported previously on American Rebel Holdings, Inc. (AREB), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
American Rebel Holdings, Inc. is positioning itself as America's Patriotic Brand. It engages in developing diverse products in the self-defense and patriotic product areas. The Company centers on designing, manufacturing, and marketing concealed carry backpacks under the American Rebel brand name. Mr. Charles A. "Andy" Ross founded the Company as America's Patriotic Brand. American Rebel Holdings has its corporate headquarters in Nashville, Tennessee. The Company lists on the OTC Markets’ OTCQB.
American Rebel’s first product offering is its line of concealed carry products. These were launched at the 2017 NRA (National Rifle Association) Annual Meeting. The design of the Company’s products is to give one the tools needed to defend and protect oneself, their family and more. The Cartwright Concealed Carry Coat by American Rebel is featured in the third installment of a five-part series in the NRA Publication America's 1st Freedom on how to choose the proper handgun to carry for defensive purposes.
This year, American Rebel Holdings is expanding its product offerings to include Large Floor Gun Safes, Wall Safes, as well as Personal Safes. Mr. Andy Ross, American Rebel Chief Executive Officer (CEO), said, "American Rebel products keep you concealed and safe inside and outside the home."
American Rebel Safes will protect one’s firearms and valuables from theft, fire, natural disasters and in a place only appropriate members of the household can access. Mr. Nathan Findley, who comes to American Rebel Holdings with more than 10 years' experience in the outdoor and firearms industries, will lead American Rebel's expansion in gun safes.
Recently, American Rebel reported sales four times greater than 2018 at the NRA Great American Outdoor Show in Harrisburg, Pennsylvania from February 2-10, 2019. The Company said that the Cartwright Concealed Carry Coats and Cartwright Concealed Carry Backpacks were the top sellers during the trade show. These were followed by the Men's Freedom Jackets. American Rebel CEO Mr. Andy Ross appeared on a recent edition of MoneyTV to report the strong results.
American Rebel Holdings, Inc. (AREB), closed Friday's trading session at $0.5099, up 32.4416%, on 7,365 volume with 6 trades. The average volume for the last 3 months is 257 and the stock's 52-week low/high is $0.150000005/$1.25.
Northsight Capital, Inc. (NCAP)
Awesome Penny Stocks, OTC Markets, InvestorsHub, GuruFocus, Insider Monkey, Stockopedia, Equity Clock, Marketwired, The Street, Equities, MarketWatch, Barchart, WhaleWisdom, Stockhouse, Simply Wall St, and Uptick Newswire reported previously on Northsight Capital, Inc. (NCAP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Northsight Capital, Inc. consists of a portfolio of online Cannabis-related websites that are undergoing development and operated by the Company. These sites incorporate numerous facets of the Cannabis industry. The Company is transitioning into two sectors. One is the Bitcoin ATM service industry. The other is its modern cannabis advertising and media platform. Northsight Capital is headquartered in Scottsdale, Arizona.
Northsight Capital does not sell or distribute any cannabis products. The Company is looking to acquire digital or publishing companies in the space. It has its 420Careers.com. This is a leading job site in the Cannabis space.
Northsight Capital also has its WeedDepot.com. This website provides consumers with a geo-targeted map directory of medical and recreational dispensaries, head shops, doctors, attorneys and more within the Cannabis industry. Weed Depot has a whole platform of content suited for every aspect of advertising and marketing to consumers from all businesses in the cannabis industry.
Northsight Capital earlier acquired Crush Mobile, LLC. Crush Mobile has developed a group of dating sites with a presence in the Latino, Israeli, and African American communities. Crush Mobile is a part of the Company’s growing media group. Crush Mobile has incorporated into its dating applications suite Northsight Capital's "Joint Lovers" dating app that centers on the Cannabis space.
Northsight Capital reached an agreement in principal in 2018 to be the exclusive distributor of CBD products for SeniorsCBD, a brand of Seniors for CBD. Northsight Capital and Seniors for CBD signed an agreement in principal to create the first CBD product line specifically for the seniors’ market. Seniors for CBD (www.SeniorsforCBD.com) is a leader in the industry for educating and informing seniors on the continuing research on medical marijuana and CBD through bringing current news each day to their followers.
This past December, Northsight Capital announced that it launched its new enhanced cannabis careers web site, www.420Careers.com. This site first launched in 2010. It is considered one of the foremost career sites in the cannabis arena. The site has been updated with many new more user-friendly features. These features make it easier for job seekers to post their resumes and also makes it easier for employers to access them. The 420Careers site has 2,000 to 3,000 visitors a day and roughly 1 million-page views per month.
Recently, Northsight Capital announced an agreement in principal to be the master distributer of 3 exclusive lines of CBD products. The initial orders will be shipped early next month. The lines include earlier announced SeniorsCBD, specializing in formulas specifically for seniors, LiquidMD, a CBD infused water, LiquidMD for pets, and Nature Grown CBD, Northsight’s generic brand.
The Company is expecting to receive the initial shipment of its CBD products on or about the first week of March. First distribution will be through Northsight's broad online media presence and also independent sales and distribution outlets.
Northsight Capital, Inc. (NCAP), closed Friday's trading session at $0.0025, up 19.0476%, on 9,500 volume with 2 trades. The average volume for the last 3 months is 733,540 and the stock's 52-week low/high is $0.001599999/$0.025.
Petro River Oil Corp. (PTRC)
Market News Updates, Real Investment Advice, The Street, Corporate Information, Simply Wall St, Oil Voice, Wolf Street, OTC Stock Review, InvestorsHub, MarketWatch, Streetwise Reports, The Energy Report, Stockhouse, Wallet Investor, GuruFocus, Market Screener, Morningstar, 4-Traders, and YCharts reported earlier on Petro River Oil Corp. (PTRC), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Petro River Oil Corp. utilizes 3D seismic technology to discover and develop oil and gas reserves in proven oil and gas basins. The Company’s core acreage is positioned in Osage County, Oklahoma. Petro River Oil owns a 14.52 percent equity interest in Horizon Energy Partners, LLC. Additionally, its President, Mr. Stephen Brunner, is a member of the Board of Managers of Horizon Energy Partners, LLC. An independent oil and gas exploration company, Petro River Oil is based in New York, New York. The Company also has an office in Kingwood, Texas.
Petro River Oil’s Management team has drilled more than 800-plus successful wells in the vicinity of the Company’s 87,754 acre Pearsonia West Lease Concession in Osage County, Oklahoma. Management’s historic success rate in the area is 90 percent.
Petro River Oil’s emphasis is on high rate return assets. The Company’s strategy is to apply modern technology, including 3D Seismic analysis, to exploit hydrocarbon-prone resources in historically prolific plays and underexplored prospective basins. This is to build reserves and to create value for Petro River Oil and its shareholders.
Petro River Oil has successfully drilled three additional wells and discovered two new oil fields in Osage County, Oklahoma since the end of April 2018. These are the North Blackland field and the Arsaga field. The success of the Company’s most recent exploration well, the Arsaga 25-2, was announced in July of 2018. Preliminary results indicated 30 feet of productive Mississippian Chat formation, with an estimated ultimate recovery of 50,655 barrels of oil equivalent based on the Reserve Report.
The Arsaga field is Petro River Oil’s largest oil field discovery with about 2,000 prospective acres and up to 100 well locations. With the success of the Arsaga field, and the West and North Blackland fields, the Company anticipates significant cash flow from oil and gas production this year.
At the end of July 2018, Petro River Oil announced its year end April 30, 2018 financials and 2018 guidance. Highlights include a 1,131 percent increase in oil and gas production in fiscal year 2018 from fiscal year ending April 30, 2017. Company production ramped up, with greater than 60 percent of the new production occurring in Q4.
Highlights also include a 395 percent increase in proved and probable reserves in fiscal year 2018 per the May 1, 2018 evaluation (Reserve Report) by independent engineering firm Cawley, Gillespie & Associates. Moreover, highlights include an 11.27 percent decrease in general and administrative expenses for fiscal year 2018.
Petro River Oil Corp. (PTRC), closed Friday's trading session at $0.30, up 7.14%, on 9,958 volume with 8 trades. The average volume for the last 3 months is 17,690 and the stock's 52-week low/high is $0.2900/$1.5300.
Creative Medical Technology Holdings, Inc. (CELZ)
Live Trading News, MarketWatch, Emerging Growth, Stockhouse, Bio Quick News, Capital Cube, OTC Markets, InvestorsHub, Canadian Insider, and 4-Traders reported earlier on Creative Medical Technology Holdings, Inc. (CELZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Creative Medical Technology Holdings, Inc. (CMT) is a clinical stage stem cell company listed on the OTC Markets Group’s OTCQB. The Company’s focus is on Urology and Neurology using stem cell treatments. Since 2011, CMT and its affiliate company, Creative Medical Health, Inc., have concentrated on regenerative medical solutions for unmet Urological and Neurological needs. The Company has a patent portfolio that encompasses all treatments. CMT has its corporate office in Phoenix, Arizona.
The Company has formed CaverStem International LLC. This is a majority-owned subsidiary centered on commercializing stem cell therapy for erectile dysfunction to global physicians and their patients. CaverStem is offering the Caverstem™ technology to selected physicians in the United States that qualify according to CMT's criteria.
CMT has also established CerebroStem LLC. This majority-owned subsidiary focuses on developing stem cell therapies for brain injuries and neurodegenerative diseases. Its initial focus will be treating radiation induced brain damage.
Via its own research and collaborations with top academic institutions, CMT has acquired a pioneering stem cell (AmnioStem) and developed proprietary protocols. Moreover, the Company has built an extensive intellectual property (IP) portfolio, developed complete treatment offerings for erectile dysfunction (ED), and launched a 40-patient trial for ED at UCLA. CMT is also making advances for treating stroke using its newly acquired amniotic fluid-based stem cell.
AmnioStem is Amniotic fluid derived stem cell. The AmnioStem patent covers means to isolate, grow, and use amniotic fluid derived stem cells in a scalable and commercializable way. AmnioStem cells do not necessitate matching with the recipient, as one size fits all.
Recently, CMT announced an update of its activities. Regarding CaverStem domestic activities, the Company is continuing marketing to physicians throughout the U.S. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and growing each month. CMT anticipates reaching financial self-sufficiency by revenues from sales this year.
Creative Medical Technology Holdings, Inc. (CELZ), closed Friday's trading session at $0.0017, up 13.3333%, on 61,786,970 volume with 267 trades. The average volume for the last 3 months is 14,276,085 and the stock's 52-week low/high is $0.0013/$0.048999998.
Dakota Territory Resource Corp. (DTRC)
InvestorsHub, Zacks, Market Screener, YCharts, TradingView, Stockhouse, Barchart, Simply Wall St, Uptick Newswire, Real Investment Advice, Innovative Marketing, OTC Markets Group, Ultimate Penny Stock, MarketWatch, The Street, Marketbeat, Dividend Investor, last19k, Wallet Investor, Corporate Information, and 4-Traders reported earlier on Dakota Territory Resource Corp. (DTRC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Dakota Territory Resource Corp.’s emphasis is on the acquisition and responsible exploration and development of high caliber gold properties in the Black Hills of South Dakota. The Company maintains 100 percent ownership of three gold properties encompassing roughly 4,059 acres. These include the Blind Gold, City Creek, and Homestake Paleoplacer Properties. All of these properties are in the heart of the Homestake District. OTCQB-listed, Dakota Territory Resource is headquartered in Reno, Nevada.
The Company’s flagship property is the Blind Gold Property, which is a target for Tertiary-aged and Iron-formation gold mineralization. The Blind Gold Property is about four miles northwest and on structural trend with the historic Homestake Gold Mine.
The Homestake Gold Mine produced roughly 40 million ounces of gold through its 125-year production history. It is the largest iron-formation-hosted gold deposit in the world.
Dakota Territory’s plan is to continue its sampling program along trend of the zone of high grade gold mineralization identified by the first pass surface sampling program conducted on its 100 percent owned Blind Gold Property. The program identified a zone of high-grade gold mineralization in the Mississippian-age Pahasapa Limestone on the surface, with a peak gold assay value of 9.44 grams per tonne.
The Homestake Paleoplacer Property consists of 13 unpatented lode mining claims. These are situated one-mile north of the Homestake Open Cut. Dakota based the acquisition of its Black Hills property position on more than 44 years of combined mining and exploration experience in the Homestake District.
The Company’s City Creek Property is a target for Homestake iron-formation gold mineralization. City Creek consists of 21 unpatented lode mining claims. These are positioned one-mile northeast of the Homestake Open Cut and one-mile northwest of the City of Deadwood.
Recently, Dakota Territory Resource announced the appointment of Mr. Lee Graber to the Company’s Strategic Advisory Committee. Mr. Graber has more than four decades of experience in the mining industry. This includes 23 years with Homestake Mining Company, one of the largest gold mining companies in the U.S. until it was acquired in 2002 by Barrick Gold Corporation.
As Homestake's Vice President responsible for corporate development, Mr. Graber initiated, managed, and closed manifold joint venture agreements, major acquisitions, and divestment transactions. After Homestake, Mr. Graber served as Managing Director, Mergers and Acquisitions, for Endeavour Financial Ltd.
Dakota Territory Resource Corp. (DTRC), closed Friday's trading session at $0.07, off by 4.3716%, on 40,664 volume with 11 trades. The average volume for the last 3 months is 21,731 and the stock's 52-week low/high is $0.019999999/$0.191750004.
The QualityStocks Company Corner
- Youngevity International, Inc. (NASDAQ: YGYI)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
- Trxade Group Inc. (TRXD)
- Sugarmade, Inc. (SGMD)
- Golden Developing Solutions, Inc. (DVLP)
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
- City View Green Holdings Inc. (CSE: CVGR)
- VPR Brands, LP (VPRB)
- SinglePoint, Inc. (SING)
- ORHub Inc. (ORHB)
- Hemptown USA
Youngevity International, Inc. (NASDAQ: YGYI)
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning announced that it is adding Pet Chews to its HEMP FX(TM) line of hemp infused products. To view the full press release, visit: http://nnw.fm/6bt7W.
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.
Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.
Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.
Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.
Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Essential Oils
- Photo and scrapbooking
- Services for Home and Business
Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.
Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.
Youngevity International, Inc. (NASDAQ: YGYI), closed Friday's trading session at $5.02, up 1.2097%, on 81,366 volume with 484 trades. The average volume for the last 3 months is 99,467 and the stock's 52-week low/high is $3.56999993/$16.25.
- Youngevity International Inc. (NASDAQ: YGYI) Adds Pet Chews to HEMP FX Line, Brand Featured in Forbes Article
- Youngevity International, Inc. (YGYI) to Release 2019 Second Quarter and Six-Month Results and Host Conference Call to Review Financial Statements and Provide Corporate Update
- 420 with CNW – Texas State Police Memo Instructs Officers to Stop Cannabis Possession Arrests
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. Luxembourg’s health minister has confirmed that the country plans to legalize recreational marijuana and he has urged other European Union (EU) member states to relax their own marijuana laws. If the country ends prohibition, it will be the first European country to take this bold step in defiance of UN conventions on the matter.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Friday's trading session at $3.4822, up 0.094858%, on 66,459 volume with 88 trades. The average volume for the last 3 months is 49,797 and the stock's 52-week low/high is $2.51999998/$6.00810003.
- 420 with CNW – Luxembourg Reveals Intention to Become First in Europe to Legalize Marijuana
- PLUS Products Donates $60,000 to the SF LBGT Center from Sales Proceeds of Its Pride-Themed Rainbow Sorbet Gummies
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Debuts New Look for Cannabis Line
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular augmented reality interactive entertainment games and toys in China, today announced the issuance and sale of an additional 141,114 ordinary shares, each priced at $4, before underwriting discounts and commissions, per the exercise of the underwriter’s over-allotment option in connection with its previously announced underwritten initial public offering (“IPO”). To view the full press release, visit: http://nnw.fm/yUQp0.
Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.
Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.
Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.
Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.
The company has multiple products in development including new generations of four primary product lines and two new product lines.
Patents and Copyrights
Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.
Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.
Sales and Marketing
There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.
In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.
Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.
Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.
CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.
Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.
Blue Hat Interactive Entertainment Technology (BHAT), closed Friday's trading session at $3.97, up 5.8667%, on 175,287 volume with 454 trades. The average volume for the last 3 months is 322,770 and the stock's 52-week low/high is $3.5999999/$6.25.
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Issuance, Sale of Additional Shares Per Exercise of Underwriter’s Over-Allotment Option in IPO
- Blue Hat Interactive Entertainment Technology Announces Exercise and Closing of Underwriter’s Over-Allotment Option in IPO
- Coverage Initiated for Blue Hat Interactive Entertainment Technology via NetworkNewsWire
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), committed to production of organic cannabis, has been named one of the eco-friendliest cannabis firms in Canada. Corporate Knights, a Toronto-based publication, gave TGOD a 100 percent organic rating and cited its projected million square foot, ecologically efficient greenhouse in Valleyfield, Quebec (scheduled to operate later this year on renewable hydropower), as being a key component in the company’s anticipated growth (http://nnw.fm/3XkOg).
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Friday's trading session at $2.5884, up 1.1094%, on 600,274 volume with 638 trades. The average volume for the last 3 months is 526,226 and the stock's 52-week low/high is $1.60699999/$7.89379978.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Named Among Greenest Cannabis Firms, Renews Health Canada Licenses
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Submits Application for NASDAQ Listing
- The Green Organic Dutchman Holdings to Release Second Quarter 2019 Earnings Results After Market Close on August 13, 2019
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
Automotive technology innovator Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) this morning announced financial results for the second quarter and first half of 2019. To view the full press release, visit: http://nnw.fm/iSgR8.
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.
Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.
The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.
Foresight has developed three main products:
- QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
- Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
- Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.
In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.
Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.
Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.
Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.
Foresight Autonomous Holdings Ltd. (FRSX), closed Friday's trading session at $1.70, up 1.7964%, on 11,478 volume with 57 trades. The average volume for the last 3 months is 524,987 and the stock's 52-week low/high is $0.697000026/$3.16000008.
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Releases Q2 and First Half 2019 Financial Results
- Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) QuadSight(TM) Prototype Ordered by American Subsidiary of Leading Global Supplier
- Foresight Receives Order of QuadSight™ Prototype from Leading Japanese Tier One Supplier
Trxade Group Inc. (TRXD)
Integrated pharmaceutical services company Trxade Group (OTCQB: TRXD) recently received approval from the Securities and Exchange Commission (“SEC”) on its S-1 Registration Statement concerning the intermittent resale of TRXD’s stock by its shareholders. To view the full article, visit: http://nnw.fm/qYJt3.
Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.
Trxade will leverage and scale its fully integrated model to execute the following growth strategies:
- Increase share of pharmacist drug purchasing
- Additional SKUs and expand product breath
- Partner with Specialty and International Mfg.
- Expand mail order licenses to all 50 states
- Scale Delivmeds for consumer delivery nationwide
- Integration with telemedicine
- M&A Opportunities within drug value chain
Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.
The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.
Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.
Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!
Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.
The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.
Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.
These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.
Health Care Market
The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.
Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.
Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.
TRxADE's programs include:
- TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
- RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
- Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.
Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.
Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.
Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.
Trxade Group Inc. (TRXD), closed Friday's trading session at $0.75, up 7.1429%, on 6,900 volume with 8 trades. The average volume for the last 3 months is 2,607 and the stock's 52-week low/high is $0.230000004/$0.75.
- Trxade Group Inc. (TRXD) Receives SEC Approval, Enhances Transparency
- Trxade Group Inc. (TRXD) Foresees Growth Opportunities in 2019, New Product Offerings on the Way
- Trxade Group Inc. (TRXD) Reports Ongoing Revenue Records in Second Quarter Financial Filing
Sugarmade, Inc. (SGMD)
Sugarmade Inc. (OTCQB: SGMD), a product and brand marketing company investing in products and brands with disruptive potential, initially entered the burgeoning hemp sector through hydroponics. Today, Sugarmade is one of the leading providers of hydroponic equipment and supplies in the industrial hemp space.
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Friday's trading session at $0.012, up 23.0769%, on 2,034,908 volume with 75 trades. The average volume for the last 3 months is 3,698,318 and the stock's 52-week low/high is $0.00975/$0.197500005.
- Sugarmade Inc. (SGMD) Enters Kentucky Hemp Boom, Announces Completion of BZRTH Audit
- Sugarmade Inc. Featured in Broadcast Discussing Kentucky as Hemp Hot Spot
- Sugarmade Inc. (SGMD) Announces Commencement of Hemp Cultivation with Hempistry, Inc.
Golden Developing Solutions, Inc. (DVLP)
Golden Developing Solutions (OTC: DVLP), an emerging leader in the cannabis, hemp and cannabidiol (“CBD”) marketplace, recently achieved fully reporting status with the Securities and Exchange Commission (“SEC”). To view the full article, visit: http://nnw.fm/dU4GF.
Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.
Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.
DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.
WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.
“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”
The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.
“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”
Golden Developing Solutions, Inc. (DVLP), closed Friday's trading session at $0.01025, up 0.490196%, on 442,436 volume with 17 trades. The average volume for the last 3 months is 2,231,236 and the stock's 52-week low/high is $0.0081/$0.14.
- Golden Developing Solutions Inc. (DVLP) Attains Fully Reporting Status
- 420 with CNW - Colorado Lawmakers Pass Bill Allowing Medical Marijuana as Alternative to Opioids
- Golden Developing Solutions Inc. (DVLP) Building Robust Portfolio of CBD Businesses
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, on Thursday announced that it has received conditional approval from the Toronto Stock Exchange (“TSX”) to uplist its common shares from the TSX Venture Exchange (“TSXV”). To view the full press release, visit: http://nnw.fm/AWnQ6.
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Friday's trading session at $5.66, off by 0.352113%, on 552,920 volume with 2,459 trades. The average volume for the last 3 months is 1,079,119 and the stock's 52-week low/high is $2.97000002/$8.43999958.
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Receives Conditional Approval to Uplist to the TSX
- How China’s Rising Cosmetics Market for Men Could Be a Big Boost for CBD
- Five of the Top Hemp Stocks to Watch in 2019
City View Green Holdings Inc. (CSE: CVGR)
City View Green Holdings (CSE: CVGR), a vertically integrated cannabis company focused on seed to retail, recently added experienced industry executives Mike Hagopian and Mario Meek to its management team. To view the full article, visit: http://nnw.fm/KW8Ih.
City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.
CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.
Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.
Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.
The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.
City View Green Holdings Inc. (CSE: CVGR), closed Friday's trading session at $0.125, off by 3.85%, on 159,034 volume with 12 trades. The average volume for the last 3 months is 109,386 and the stock's 52-week low/high is $0.094999998/$0.465000003.
- City View Green Holdings Inc. (CSE: CVGR) Strengthens Executive Team
- City View Green Holdings Inc. (CSE: CVGR) Closes Sale, Leaseback of Brantford Facility
- City View Green Holdings Inc. (CSE: CVGR) Strengthening Finance Strategy, Constructing Cannabis Production Facility Near Toronto
VPR Brands, LP (VPRB)
VPR Brands LP (OTC: VPRB), an innovative technology holding company, offers high-quality products with a goal to bring value to its partners, consumers and investors. To view the full article, visit: http://nnw.fm/TF3g1.
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed Friday's trading session at $0.0447, off by 2.8261%, on 94,533 volume with 9 trades. The average volume for the last 3 months is 56,067 and the stock's 52-week low/high is $0.035/$0.119999997.
- VPR Brands LP (VPRB) on Track to be Vaping Market Trailblazer
- VPR Brands LP (VPRB) Anticipates Positive Impact from Legislation, Launches Turbo Vaporizer
- VPR Brands LP (VPRB) Remakes Vaping Experience with Pre-Market Release of HoneyStick BeeBox Pro Device
SinglePoint, Inc. (SING)
Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. To view the full press release, visit: http://nnw.fm/5k8EG. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Luxembourg’s health minister has confirmed that the country plans to legalize recreational marijuana and he has urged other European Union (EU) member states to relax their own marijuana laws. If the country ends prohibition, it will be the first European country to take this bold step in defiance of UN conventions on the matter.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Friday's trading session at $0.01315, off by 5.9034%, on 3,067,478 volume with 78 trades. The average volume for the last 3 months is 5,802,967 and the stock's 52-week low/high is $0.009999999/$0.041000001.
- SinglePoint, Inc. (SING) President Discusses Rapidly Growing CBD Business on MoneyTV with Donald Baillargeon
- 420 with CNW – Luxembourg Reveals Intention to Become First in Europe to Legalize Marijuana
- SinglePoint Becomes Master Distributor for Pure Hemp Cigarettes
ORHub Inc. (ORHB)
ORHub Inc. (ORHB) is a growth-stage data analytics company on a mission to optimize the business of surgery through lean process improvement. As a Microsoft Silver Partner, ORHub leverages the Azure cloud to help customers unlock the power of data captured in the operating room by surfacing key business indicators into a curated set of dynamic dashboards.
ORHub’s Surgical Spotlight® is a cloud-based analytics tool that helps administrators, nurse leaders and surgeons make improved business decisions for the operating room. By taking data feeds from the facility’s Operating Room Information System, ORHub produces a functional and elegant dashboard that allows users to easily identify opportunities for improvement.
These capabilities allow providers to harness data, identify millions of dollars in opportunities, and get leaders back to their primary focus of improving care, increasing patient access and reducing costs. A first-of-kind team building tool brings all stakeholders together with regular and accessible information. ORHub specializes in business intelligence for the operating room, built by professionals with experience in the operating room.
Surgical Spotlight video featuring renowned cardiac surgeon and ORHub Chief Medical Officer Dr. Robert (“Bobby”) Lazzara
ORHub is proud to partner with top tier facilities and organizations, including:
- Hoag Orthopedic Institute & Hoag Memorial Hospital in the Providence network
- Baptist Health, Jacksonville
- Alvarado Hospital Medical Center in the Prime network
- Orthopedic Institute Surgery Center in the SMP network
- Metropolitan Surgery Center in the USPI network
- Anderson Regional Medical Center
ORHub has attended and presented at several events in 2019, also gaining approval to present Surgical Spotlight® at nursing forums and offer 1.2 contact hours toward Continuing Education Units (CEU) from Terri Goodman, RN, PhD, & Associates, an approved provider by the California Board of Registered Nursing (provider number CEP 16550).
The U.S. surgical market continues to grow, with over 5,500 hospitals and 6,100 ambulatory surgery centers (ASCs) performing over 50 million medical procedures annually. According to MarketsandMarkets, the global health care analytics market will approach $50 billion by 2024 with a five-year Compound Annual Growth Rate (“CAGR”) of 28.3% from 2019.
Chief Executive Officer Colt Melby has over 30 years of experience in both public and private companies as a senior level executive. He is an active entrepreneur and investor who focuses on high-growth companies.
Chief Financial Officer Barney Monte has more than 20 years of global investment banking and capital markets experience. He has worked with numerous growth stage companies.
Chief Medical Officer Dr. Robert “Bobby” Lazzara is a distinguished cardiac surgeon, a medical media expert, and founder of Medical News Minute. He performed the first worldwide webcast of open-heart surgery in August 1998 through the Virtual Operating Room and is a Smithsonian Laureate for his pioneering work utilizing the internet and information technology as a health care educational tool. Dr. Lazzara has been a member of advisory boards and a consultant to major corporations and medical device companies.
ORHub Inc. (ORHB), closed Friday's trading session at $0.087, even for the day, on 2,300 volume with 2 trades. The average volume for the last 3 months is 116,679 and the stock's 52-week low/high is $0.020999999/$0.670000016.
- ORHub, Inc. Settles Litigation with Former Chief Financial Officer
- Renowned Cardiac Surgeon and Medical News Minute Founder, Dr. Robert Lazzara, Joins ORHub Team as Chief Medical Officer
- ORHub, Inc. (ORHB) Secures Contract with Anderson Regional Medical Center
The QualityStocks Daily Newsletter would like to spotlight Hemptown USA.
Hemptown USA, headquartered in Central Point, Oregon, is a proven grower of full-spectrum hemp biomass grown using premium seed genetics that contain less than 0.3% THC and exceptionally high cannabinoid (CBD) content of up to 20%. The company's "soil to oil" methodology combines seasoned professionals working in hand-picked agricultural microclimates located in Oregon's famed Emerald Triangle, Kentucky and Colorado.
Hemptown has exclusive rights to 1 million rare CBG (cannabigerol) seeds genetically programmed to yield from 15% to 20% full-spectrum non-intoxicating cannabinoids. As a result of a long-standing relationship with the one of the world's most respected cannabis breeding companies – Oregon CBD Seeds – Hemptown is positioned to be a leading CBG producer in the U.S. in 2019 and beyond.
In 2018 Hemptown's harvest from its Oregon hemp farm was 150,000 pounds of full-spectrum biomass with CBD content hovering around 17%. 2018 harvest revenue expected to range from $8.1 million to $12.6 million. The company is scaling up operations in 2019 to meet market demands and projects it will reap over 1,000,000 pounds. By 2020, Hemptown projects potential revenues in the $100 million to $200 million range are possible once additional farming operations are at full strength.
By 2020, Hemptown anticipates it will have more than 3,000 acres in several states dedicated to hemp farming. Expansion plans include increasing in-house extraction capabilities to boost profit margins by providing additional CBD and CBG isolates and distillation services. Development of business-to-business channels as well as new products and formulations for the direct-to-consumer market, along with several strategic acquisitions, are also key to Hemptown's growth strategy.
Hemptown plans to expand distribution and growing operations globally through strategic partnerships and development of contracts with leading Fortune 500 brands in European markets. The company intends to grow its IP portfolio by developing a proprietary water-soluble cannabinoid delivery system. Not to be confused with water-compatibility, water-soluble cannabinoids combine seamlessly with other liquids, have a superior shelf life, and deliver dramatically increased efficacy to the consumer.
Hemptown's first in-house branded product line combines the inspiring strength found in the unbridled nature that surrounds the company's original hemp farm in the Siskiyou Klamath region of Oregon. Sisku is set to redefine the cannabinoid packaged goods space with an elegant look, clean feel and potent, reliable efficacy.
Custom product lines can also be created for any product manufacturer as Hemptown brings GMP and ISO accredited processing facilities online in 2019. Together with Oregon CBD Seeds and Hemptown's product sciences team, Hemptown will be able to create custom, proprietary full-spectrum CBD and CBG oils and pure isolates.
Company Chairman Rod Wolterman founded Hemptown's Oregon operations in 2016. He has extensive experience in the cannabis sector having been active within the space since 1998. Wolterman has also acted as a private equity investor in numerous medical marijuana dispensaries and cultivation operations in southern California.
CEO John Cummings has over 20 years of experience in finance, marketing, sales and project management. He led the compliance and special projects efforts for Kings Garden, one of the largest vertically integrated operators in California. Cummings also spent a year in Europe launching the continent's first GMP and ISO-accredited cultivation and manufacturing facility.
Dr. Gordon Chiu is chief science officer for Hemptown USA. He has more than 15 years of combined domestic and international experience in biomedical, chemical, cosmetic, medical and technology industries. A graduate of Rensselaer Polytechnic Institute with a master's degree from Seton Hall University, Chiu is leading Hemptown's cannabinoid research team and is responsible for filing IP patents, specifically in the areas of water-solubility, bioavailability and peptide sequencing.
- Hemptown USA Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- Hemptown USA Acquires Leading Nutraceutical Manufacturing Facility
- Keeping Hemp Production Costs Low through Technology: How Hemptown USA is Changing the Lucrative Market
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Exercise and Closing of Underwriter’s Over-Allotment Option in IPO
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – Texas State Police Memo Instructs Officers to Stop Cannabis Possession Arrests
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Portfolio Company YSS Receives 12th Cannabis Retail Licence in Alberta
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – NYC Council Passes Two Cannabis Reform Resolutions
- ChineseInvestors.com (CIIX) Board of Directors Appoints Shelby Chan as it's Newest Independent Director
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green Holdings Inc. (CSE: CVGR) Closes Sale, Leaseback of Brantford Facility
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Reports Strong Attendance at Signature Fun Runs
- Earth Science Tech, Inc. (ETST) Subsidiaries Heighten Global CBD Presence
- Endonovo Therapeutics (OTCQB: ENDV) Positioning SofPulse as Natural Post-Surgical Alternative to Opioids
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) QuadSight(TM) Prototype Ordered by American Subsidiary of Leading Global Supplier
- Genprex Inc. (NASDAQ: GNPX) Manufacturing Partner Aldevron Completes Significant Step in Manufacturing for Oncoprex Clinical Development Program
- Geyser Brands Inc. (TSX.V: GYSR) CBD Pet Care: One of the Fastest Growing Wellness Market Segments
- Golden Developing Solutions, Inc. (DVLP) 420 with CNW - Colorado Lawmakers Pass Bill Allowing Medical Marijuana as Alternative to Opioids
- Grapefruit Boulevard Investments Inc. (IGNG) Launches “Rainbow Dreams” – A New Line of Flavored CBD THC Oil Infused Vaporization CCell Cartridges
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) It Appears Consumers Preferences are Shaping the Retail Cannabis Market’s Direction
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – Oregon Law Forbids the Sale of Marijuana Byproducts
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- INmune Bio, Inc. (NASDAQ: INMB) Appoints Biotechnology Executive Edgardo Baracchini as New Board Member
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Announces Its Zoots Premium Cannabis Infused Edibles Launch in Pharmacann’s Illinois Dispensaries
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Completes Initial Project with Canada's National Research Council
- Marijuana Company of America Inc. (MCOA) Announces Virtual Launch Party of Cannabis Delivery Service VivaBuds
- MustGrow Biologics Corp (CSE: MGRO) 420 with CNW – Florida Personal Injury Lawyer Turns Around and Decides to Back Marijuana Legalization Drive
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Enters World’s Largest Cannabis Industry Market through Acquisition of California Dispensary
- Nightfood, Inc. (OTCQB: NGTF) Sports Influencers and Consumer Branding - It's a Win-Win
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) How China’s Rising Cosmetics Market for Men Could Be a Big Boost for CBD
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) President Issues Letter to Shareholders
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Achieves Key Milestone of Form 10 Registration Statement Effectiveness
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Donates $60,000 to the SF LBGT Center from Sales Proceeds of Its Pride-Themed Rainbow Sorbet Gummies
- Pressure BioSciences Inc. (PBIO) Solves CBD Water-Solubility Problem with Patented UST Platform
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Holds Favorable Position as Rising EV Market Boosts Lithium Demand Worldwide
- Sharing Services Global Corporation (SHRG) Revolutionizing Direct-Selling Industry
- SinglePoint, Inc. (SING) Becomes Master Distributor for Pure Hemp Cigarettes
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Receipt of $300K Software Supply Contract
- Spectrum Global Solutions, Inc. (SGSI) Targets Growing Demands of $1.5 Trillion Telecommunications Market
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – Colorado Nurses to Launch Cannabis Information Hotline
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Files Preliminary Economic Assessment and Updated Mineral Resource Technical Report for Its Southern Arkansas Lithium Brine Project
- Sugarmade, Inc. (SGMD) Featured in Broadcast Discussing Kentucky as Hemp Hot Spot
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Pursuing Growth through Partnerships, Added Talent
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Submits Application for NASDAQ Listing
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Continues Testing of TherOZap(TM) Technology Against the Zika Virus
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) 420 with CNW – Thousands Submit Comments Urging FDA to Allow CBD in Supplements and Foods
- Trxade Group Inc. (TRXD) Foresees Growth Opportunities in 2019, New Product Offerings on the Way
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Announces 50% Increase in Licensed Capacity and Third Licensed Site with New Innovative Seasonal Greenhouses
- VPR Brands, LP (VPRB) Anticipates Positive Impact from Legislation, Launches Turbo Vaporizer
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Receives Subscriptions for $1,325,000 Convertible Debenture Financing
- Willow Biosciences Inc. (CSE: WLLW) New Cannabis Stocks Added to Investor Ideas
- Youngevity International, Inc. (NASDAQ: YGYI) to Release 2019 Second Quarter and Six-Month Results and Host Conference Call to Review Financial Statements and Provide Corporate Update
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.